Pubblicazioni

IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Lawless, S; Sbianchi, G; Morris, C; Iacobelli, S; Bosman, P; Blaise, D; Remenyi, P; Byrne, Jl; Mayer, J; Apperley, J; Lund, J; Kobbe, G; Schaap, N; Isaksson, C; Lenhoff, S; Basak, G; Touzeau, C; Wilson, Kmo; Muniz, Sg; Scheid, C; Browne, P; Anagnostopoulos, A; Rambaldi, A; Jantunen, E; Kroger, N; Schonland, S; Yakoub-Agha, I; Garderet, L

Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors

2018 - MEDICINE

Balan, Daniel; Martha, Orsolya; Chibelean, Calin Bogdan; Tataru, Sabin; Voidezan, Septimiu; Sin, Anca; Matei, Victor Deliu; Vartolomei, Mihai Dorin; Lucarelli, Giuseppe; Cioffi, Antonio; Del Giudice, Francesco; De Berardinis, Ettore; Borda, Angela; Busetto, Gian Maria; Ferro, Matteo; Pytel, Akos; Porav-Hodade, Daniel